{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01061099",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2008-4-5947"
      },
      "Organization": {
        "OrgFullName": "Nationwide Children's Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta",
      "OfficialTitle": "A Pilot Study to Assess the Safety and Feasibility of Repeated Infusions of Mesenchymal Stromal Cells (MSC) in Children With Osteogenesis Imperfecta",
      "Acronym": "STOD3"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 2010"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2013",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 2014",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "February 1, 2010",
      "StudyFirstSubmitQCDate": "February 1, 2010",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 2, 2010",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 23, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 24, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Edwin Horwitz",
        "ResponsiblePartyInvestigatorTitle": "Attending Physician",
        "ResponsiblePartyInvestigatorAffiliation": "Nationwide Children's Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Nationwide Children's Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is a study to evaluate the safety and effectiveness of repeated Mesenchymal Stromal Cells (MSC) infusions to patients with Type II or III osteogenesis imperfecta (OI).\n\nParticipants will receive MSC infusions approximately every 4 months to complete a total of 6 infusions over 20 months. Participants will be followed for 4 months post their last MSC infusion.",
      "DetailedDescription": "This is a pilot study to evaluate the safety and efficacy of repeated MSC infusions to subjects with OI. This study will evaluate subjects on two separate strata. Stratum A will include subjects with a diagnosis of Type II or Type III osteogenesis imperfecta who have previously undergone a bone marrow transplant. Stratum A may use previously harvested and cryopreserved bone marrow mononuclear cells from original BMT donor or freshly harvested or cryopreserved bone marrow mononuclear cells obtained from a haploidentical healthy parent or sibling. Stratum B will include subjects with Type II or III osteogenesis imperfecta who have not undergone a bone marrow transplant. Stratum B will only receive freshly harvested or cryopreserved bone marrow mononuclear cells from a haploidentical healthy parent or sibling.\n\nParticipants will receive MSC infusions approximately every 4 months to complete a total of 6 infusions over 20 months. Participants will be followed for 12 months post their last MSC infusion."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteogenesis Imperfecta Type II",
          "Osteogenesis Imperfecta Type III"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Type II or Type III Osteogenesis imperfecta",
          "OI",
          "Mesenchymal Stromal Cells",
          "MSC"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "5",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Stratum A",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Subjects with a diagnosis of Type II or Type III osteogenesis imperfecta who have previously undergone a bone marrow transplant. Intervention: Mesenchymal Stromal Cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stromal Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Stratum B",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Subjects with Type II or III osteogenesis imperfecta who have not undergone a bone marrow transplant. Intervention: Mesenchymal Stromal Cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stromal Cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stromal Cells",
            "InterventionDescription": "Both cohorts will receive multiple infusions of ex-vivo expanded MSCs. Stratum A may use previously harvested and cryopreserved bone marrow mononuclear cells from original BMT donor or freshly harvested or cryopreserved bone marrow mononuclear cells obtained from a haploidentical healthy parent or sibling. Stratum B will only receive freshly harvested or cryopreserved bone marrow",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Stratum A",
                "Stratum B"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "ex-vivo expanded MSCs"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "To determine the safety or repeated infusions of donor-derived and MSCs in subjects with severe osteogenesis imperfecta > 5years after an allogeneic bone marrow transplant and no prior bone marrow transplant.",
            "PrimaryOutcomeTimeFrame": "Completion of study"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "To determine if MSCs elicit an immune response after repeated infusions.",
            "SecondaryOutcomeTimeFrame": "Completion of study"
          },
          {
            "SecondaryOutcomeMeasure": "To determine the change in clinical course (growth, bone mineral content, fracture rate, development/activities) of subjects after experimental MSC intervention therapy as compared with each subject's own pre-MSC intervention therapy.",
            "SecondaryOutcomeTimeFrame": "Completion of Study"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects less than or equal to 19 years of age at the time of enrollment\nChildren with a diagnosis of severe of Type II or III osteogenesis imperfecta\nParent or sibling greater than or equal to 18 years of age, donor willing to or has already undergone HLA typing, and willing and able to provide bone marrow\nBMT greater than 5 years ago for Stratum A\n\nExclusion Criteria:\n\nDependent on supplemental oxygen\nConcurrent Infection",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MaximumAge": "19 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Alix Seif, MD",
            "OverallOfficialAffiliation": "Children's Hospital of Philadelphia",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "The Children's Hospital of Philadelphia",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationZip": "19104",
            "LocationCountry": "United States"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "12084934",
            "ReferenceType": "background",
            "ReferenceCitation": "Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8932-7."
          },
          {
            "ReferencePMID": "11222364",
            "ReferenceType": "background",
            "ReferenceCitation": "Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001 Mar 1;97(5):1227-31."
          },
          {
            "ReferencePMID": "10086387",
            "ReferenceType": "background",
            "ReferenceCitation": "Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999 Mar;5(3):309-13."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010013",
            "ConditionMeshTerm": "Osteogenesis Imperfecta"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010009",
            "ConditionAncestorTerm": "Osteochondrodysplasias"
          },
          {
            "ConditionAncestorId": "D000001848",
            "ConditionAncestorTerm": "Bone Diseases, Developmental"
          },
          {
            "ConditionAncestorId": "D000001847",
            "ConditionAncestorTerm": "Bone Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionAncestorId": "D000003095",
            "ConditionAncestorTerm": "Collagen Diseases"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12088",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M12084",
            "ConditionBrowseLeafName": "Osteochondrodysplasias",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11195",
            "ConditionBrowseLeafName": "Mucopolysaccharidosis IV",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4278",
            "ConditionBrowseLeafName": "Bone Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4279",
            "ConditionBrowseLeafName": "Bone Diseases, Developmental",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4306",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T4313",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type VI",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T4309",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type III",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type III",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T4308",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type II",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type II",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T3909",
            "ConditionBrowseLeafName": "Mucopolysaccharidosis Type IV",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}